impf-info.de
Nachdem Covid19 aus medizinischer Sicht "durch" ist, hier jetzt also wieder das Thema Impfen in ganzer Breite...
Omikron-spezifische Nicht-Lebend-Impfstoffe in klinischen Studien
Omicron-specific Sinopharm, Sinovac COVID vaccine candidates cleared for clinical trial | Reuters
COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech to target the Omicron variant were approved for clinical trials in Hong Kong, the companies said on Saturday.
By accepting you will be accessing a service provided by a third-party external to https://impf-info.de/
